Champions Oncology Inc Capital Reinvestment Ratio
Champions Oncology Inc capital reinvestment ratio. Champions Oncology Inc (CSBR) has a Capital Reinvestment Ratio of 0.08x as of July 2025, meaning it reinvests 0% of its operating cash flow ($600.00K) in capital expenditures ($46.00K). Check CSBR capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Champions Oncology Inc (1997–2025)
Capital reinvestment ratio of Champions Oncology Inc from 1997 to 2025. This chart tracks Champions Oncology Inc's Capital Reinvestment Ratio across 9 annual periods. Also explore net asset growth rate of Champions Oncology Inc to track the company's year-over-year net asset growth rate.
Champions Oncology Inc Capital Reinvestment Ratio by Year (1997–2025)
Champions Oncology Inc capital reinvestment ratio by year from 1997 to 2025. For the full cash flow conversion analysis, see how efficiently does Champions Oncology Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | $7.39 Million | $389.00K | ▼ -92.7% |
| 2023 | 0.73x | $3.96 Million | $2.87 Million | ▲ +97.9% |
| 2022 | 0.37x | $6.50 Million | $2.38 Million | ▼ -52.0% |
| 2020 | 0.76x | $2.90 Million | $2.22 Million | ▲ +70.6% |
| 2019 | 0.45x | $1.86 Million | $834.00K | ▲ +92.2% |
| 2001 | 0.23x | $144.68K | $33.72K | ▲ +156.4% |
| 1999 | 0.09x | $110.00K | $10.00K | ▲ +90.9% |
| 1998 | 0.05x | $420.00K | $20.00K | ▼ -47.6% |
| 1997 | 0.09x | $110.00K | $10.00K | — |